X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, ...

Bullish has said it would have about 150.7 million shares outstanding after the IPO, the underwriters exercise their option to buy an additional 4.5 million shares, for a market capitalization of ...

Compass Therapeutics, Inc. (“Compass”) (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, ...

CareTrust REIT flexed its appeal to institutional investors by raising an upsized US$640m from a follow-on stock sale late Tuesday, providing it firepower for additional acquisitions.

X4 Pharmaceuticals (XFOR) on Wednesday announced the closing of an upsized private placement of over 11 million shares of ...

SAN CLEMENTE, Calif. - CareTrust REIT, Inc. (NYSE:CTRE), a healthcare REIT with a market capitalization of $6.6 billion and ...

CareTrust REIT, Inc. (NYSE: CTRE) (“CareTrust REIT” or the “Company”) announced the pricing of its upsized underwritten public offering of 20,000,000 shares of common stock at a price to the public of ...

The company plans to sell 30 million shares at a price of $32 to $33 a share versus the previous range of $28 to $31.

DigitalOcean Holdings prices $550M convertible senior notes for 2030 in a private offering, increased from $500M.

Heartflow (HTFL) on Thursday announced the pricing of its upsized initial public offering of 16,666,667 shares of its common stock at a public offering price of $19.00 per share.

Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), a leader in AI technology for coronary artery disease (CAD), today announced the closing of its upsized initial public offering of 19,166,667 shares of its ...